PharmExec Blog
Follow Us
RSS
Bookstore
Monthly Archives: April 2010
Updated IMS Forecast Predicts Market Growth
If you look closely at the thunderclouds hovering over pharma, there is a ray of light peeking through the gloom—IMS’ updated 2009-2014 forecast has come in, and it’s a far cry from the unmitigated doom of recent years. Market growth in 2009 was 7 percent, a vast improvement over 2008’s 4.8 percent, and IMS expects [...]
US Pharma: An Expensive Free Market
US citizens may have politicians that ask probing questions on their behalf, but that doesn’t translate into them getting a better deal from pharma, says Jacky Law.
You have to hand it to Senator Herb Kohl for keeping the industry on its toes. For years the Democrat from Wisconsin has been asking awkward questions to get [...]
Posted in Strategy Leave a comment
Feds End Use of Seven Inhalers (But Not All At Once)
Image by noii’s via Flickr
FDA, on Tuesday, announced that it would phase out the use of seven asthma and chronic obstructive pulmonary disease inhalers to keep in check with regulations banning devices containing chlorofluorocarbons (CFCs).
Four of the devices have already been discontinued, and the manufacturers of the remaining devices will have to find suitable replacements [...]
Webcast: SaaS or On-premise CRM—It’s Your Choice… Not Your Vendor’s
Tuesday, April 13, 2010 at 11:00 AM ET; 8:00 AM PT; 16:00 GMT
As the life sciences industry continues to grow in complexity, its commercial model is changing too. The traditional ’single message to many’ approach to delivering your product information has been re-focused to building and maintaining relationships to achieve lasting share of mind. Given [...]
Avandia Trial in Trouble